NCT05236842View on ClinicalTrials.gov

Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)

PHASE2CompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

November 23, 2021

Primary Completion Date

August 15, 2023

Study Completion Date

August 31, 2023

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Sulthiame

oral

Trial Locations (1)

5101

Pneumocare SRL, Namur

Sponsors
All Listed Sponsors
lead

Desitin Arzneimittel GmbH

INDUSTRY

NCT05236842 - Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA) | Biotech Hunter | Biotech Hunter